Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01149616 · ClinicalTrials.gov registry record · Phase 4
Effects of Perioperative Intravenous Dexamethasone on Pain in Out Patient Knee Surgery
A Phase 4 study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 82
- Enrollment target
NCT01149616 is a Phase 4 study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 82 participants.
The verdict
NCT01149616, a Phase 4 study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 82 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the opiate sparing effects of intravenously administered dexamethasone in outpatient knee surgery. Dexamethasone is a glucocorticoid with well known antiemetic effects. However, the analgesic effects of dexamethasone have not been adequately researched. Following surgery, patients are typically discharged home with PO opiates to manage post-operative pain. The investigators believe that by using VAS (Visual Analog Scale) for Pain the investigators can show that a single dose of dexamethasone can reduce pain scales and opiate consumption post-operatively, on Post Operative Day (POD 1) when compared to placebo.
Interventions
- DRUG placebo
- DRUG Dexamethasone 8mg iv x1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01149616
The ClinicalTrials.gov registry entry for NCT01149616 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01149616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01149616 about?
NCT01149616 is a clinical study titled "Effects of Perioperative Intravenous Dexamethasone on Pain in Out Patient Knee Surgery". The purpose of the study is to determine the opiate sparing effects of intravenously administered dexamethasone in outpatient knee surgery. Dexamethasone is a glucocorticoid with well known antiemetic effects. However, the analgesic effects of dexamethasone have not been adequately researched. Follo...
What is the current status of trial NCT01149616?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 82 participants. The study started on 2009-12. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01149616?
The interventions under investigation include: placebo (DRUG), Dexamethasone 8mg iv x1 (DRUG).
Who is sponsoring clinical trial NCT01149616?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.